Ohcanbohtosat - Laia Solé-Feu

  • Čájehuvvo 1 - 3 / 3
Aiddostahte ozu
  1. 1
    Bearbmagovva

    Response to "Letter to the Editor Regarding 'Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab vs. Dupilumab in Mo... Dahkki Kim Rand, Juan Manuel Ramos-Goñi, Bülent Akmaz, Laia Solé-Feu, José-Carlos A

    Almmustuhtton 2024
    Connect to this object online.
    Girji

    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Bearbmagovva

    Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis Dahkki Kim Rand, Juan Manuel Ramos-Goñi, Bülent Akmaz, Laia Solé-Feu, José-Carlos A

    Almmustuhtton 2023
    Connect to this object online.
    Girji

    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Bearbmagovva

    Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Der... Dahkki Kim Rand, Juan Manuel Ramos-Goñi, Bülent Akmaz, Laia Solé-Feu, José-Carlos A

    Almmustuhtton 2024
    Connect to this object online.
    Girji

    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: